Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020505 (
hyperphagia
)
6,116
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prader-Willi syndrome, first described in 1956, is characterized by marked hypotonia,
hyperphagia
, severe obesity, short stature, hypogonadism, orthopedic problems, breathing-related sleep disorders, mild to moderate mental retardation and behavioral abnormalities. The incidence of this syndrome, an expression of a genetic imprinting error in chromosome 15, is 1:10,000-1:25,000. We describe the medical, emotional and cognitive parameters of 34 patients in our multidisciplinary clinic for Prader-Willi syndrome. Their ages range from 5 months to 40 years and 20 are males. Excessive weight gain started at the age of 6 years, increasing to 170-370% of that predicted by height and age and short stature started after the age of 12. All males have hypogonadism; 6 patients have scoliosis. Breathing-related sleep disorders have occurred in 15. Children above the age of 8 years underwent neuropsychological assessment: half (9/18) have borderline intelligence while a quarter have low-normal intelligence and the remainder mild to moderate mental retardation. Behavioral and social problems are common, and become more prominent during adolescence.
ADHD
was diagnosed in 10/18.
...
PMID:[Prader-Willi syndrome: medical, emotional and cognitive facets]. 1088 49
Kleine-Levin syndrome (KLS) is a rare disorder characterized by recurrent episodes of hypersomnia, disturbed behaviour, and cognitive function; it may by accompanied by
hyperphagia
/hypersexuality. KLS is often seen after a minor infection in young men but the aetiology is unknown. This case rapport illustrates how a 16-year-old boy with
ADHD
presented with a range of the above-mentioned symptoms and was assessed by neurologists, internal medicine doctors and psychiatrists. After two new episodes he was finally diagnosed with KLS. The understanding of this disorder is intriguing.
...
PMID:[Kleine-Levin syndrome is a diagnostic challenge]. 2309 55
Objective:
The
ADHD
-obesity link has been suggested to result from a shared underlying basis of suboptimal dopamine (DA); however, this theory conflicts evidence that an
amplified
DA signal increases the risk for
overeating
and weight gain. A model was tested in which
ADHD
symptoms, predicted by hypodopaminergic functioning in the prefrontal cortex, in combination with an enhanced appetitive drive, predict hedonic eating and, in turn, higher body mass index (BMI).
Method:
DRD2 and DRD4 markers were genotyped. The model was tested using structural equation modeling in a nonclinical sample (
N
= 421 adults).
Results:
The model was a good fit to the data. Controlling for education, all parameter estimates were significant, except for the DRD4-
ADHD
symptom pathway. The significant indirect effect indicates that
overeating
mediated the
ADHD
symptoms-BMI association.
Conclusion:
Results support the hypothesis that
overeating
and elevated DA in the ventral striatum-representative of a greater reward response-contribute to the
ADHD
symptom-obesity relationship.
...
PMID:A Behavioral Genetic Model of the Mechanisms Underlying the Link Between Obesity and Symptoms of ADHD. 2679 71
This is a report of
FMR1
premutation with Prader-Willi phenotype (PWP) and FXTAS. Although the PWP is common in fragile X syndrome (FXS), it has never been described in someone with the premutation. The patient presented intranuclear inclusions, severe obesity,
hyperphagia
, and
ADHD
symptoms, typical of the PWP in FXS. In addition, the autopsy revealed multiple architectural cortical abnormalities.
...
PMID:
FMR1
premutation with Prader-Willi phenotype and fragile X-associated tremor/ataxia syndrome. 2846 64
In the last decades, obesity has become a major concern for clinical and public health. Despite the variety of available treatments, the outcomes remain-by and large-still unsatisfactory, owing to high rates of nonresponse and relapse. Interestingly, obesity is being associated with a growing surge of neuropsychiatric problems, certainly related to the pathogenesis of this condition, and likely to be of great consequence as for its treatment and prognosis. In a neurobiologic direction, a sturdy body of evidence has recently shown that the immune-metabolic-endocrine dyscrasias, notoriously attached to excess body weight/adiposity, affect and impair the morpho-functional integrity of the brain, thus possibly contributing to neuroprogressive/degenerative processes and behavioral deviances. Likewise, in a neuropsychiatric perspective, obesity displays complex associations with mood disorders and affective temperamental dimensions (namely cyclothymia), eating disorders characterized by
overeating
/binge-eating behaviors,
ADHD
-related executive dysfunctions, emotional dysregulation and motivational-addictive disturbances. With this review, we attempt to provide the clinician a synoptic, yet exhaustive, tool for a more conscious approach to that subset of this condition, which could be reasonably termed "psychiatric" obesity.
...
PMID:Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology. 3271 93